GET:EURONEXT PARISGetlink SE Analysis
Data as of 2026-05-29 - not real-time
€18.86
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading just above its 20‑day moving average, suggesting the short‑term trend remains bullish. However, the MACD has turned bearish and volume is on a downtrend, indicating weakening momentum. Prices are holding just above a clear technical support zone, which may act as a floor if selling pressure intensifies. The relative strength index sits comfortably in the upper‑mid range, showing no sign of over‑extension. A dividend yield that ranks among the highest in the sector provides attractive income but is funded by a payout ratio near full earnings. Valuation metrics such as the price‑to‑earnings multiple sit above the industry average, pointing to an overvalued market price.
Underlying fundamentals remain solid, with operating margins well above peers and robust cash flow generation. The company benefits from a long‑term concession to operate the Channel Tunnel for many decades, delivering a predictable revenue base. Nonetheless, the balance sheet is heavily leveraged, with debt levels that dwarf equity, raising concerns about financial flexibility. The low beta and modest price volatility suggest limited price swings in the near term. Regulatory exposure is moderate, as the core business is governed by a stable concession framework but remains sensitive to cross‑border policy changes. Overall, the stock offers a blend of income and long‑term infrastructure stability, but the current premium price warrants a cautious stance.
Underlying fundamentals remain solid, with operating margins well above peers and robust cash flow generation. The company benefits from a long‑term concession to operate the Channel Tunnel for many decades, delivering a predictable revenue base. Nonetheless, the balance sheet is heavily leveraged, with debt levels that dwarf equity, raising concerns about financial flexibility. The low beta and modest price volatility suggest limited price swings in the near term. Regulatory exposure is moderate, as the core business is governed by a stable concession framework but remains sensitive to cross‑border policy changes. Overall, the stock offers a blend of income and long‑term infrastructure stability, but the current premium price warrants a cautious stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Bearish MACD momentum
- Decreasing trading volume
- Proximity to technical support
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong dividend yield
- Robust operating margins
- High leverage and overvaluation
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Multi‑decade concession providing stable cash flows
- Low beta and limited price volatility
- Attractive income from dividend despite premium price
Key Metrics & Analysis
Financial Health
Revenue Growth12.40%
Profit Margin19.39%
P/E Ratio32.0
ROE12.18%
ROA4.32%
Debt/Equity190.82
P/B Ratio3.7
Op. Cash Flow€816.0M
Free Cash Flow€208.3M
Industry P/E29.9
Technical Analysis
TrendBullish
RSI57.0
Support€18.50
Resistance€19.50
MA 20€18.74
MA 50€18.64
MA 200€16.69
MACDBearish
VolumeDecreasing
Fear & Greed Index94.07
Valuation
Fair Value€1.57
GradeOvervalued
TypeBlend
Dividend Yield4.24%
Risk Assessment
Beta0.26
Volatility10.41%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.